clarithromycin has been researched along with Myocardial Ischemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrillo-Alascio, PL; Guirao-Arrabal, E; León-Ruíz, L; Pérez-Sola, MJ | 1 |
| Abildstrøm, SZ; Andersen, SS; Folke, F; Fosbøl, EL; Gislason, GH; Hansen, ML; Køber, L; Madsen, M; Norgaard, ML; Raunsø, J; Torp-Pedersen, C | 1 |
| Muhlestein, JB | 1 |
| Fraser, V; Sultan, F; Tebas, P; Wallace, RJ | 1 |
| Arosio, C; Bertinieri, G; Blasi, F; Ceriani, G; Cosentini, R; Mandelli, C; Perondi, R; Ranzi, ML; Tarsia, P; Tien, TV; Torgano, G | 1 |
1 review(s) available for clarithromycin and Myocardial Ischemia
| Article | Year |
|---|---|
Antibiotic treatment of atherosclerosis.
Topics: Animals; Anti-Bacterial Agents; Arteriosclerosis; Azithromycin; C-Reactive Protein; Cardiovascular Diseases; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Coronary Artery Disease; Coronary Restenosis; Diet, Atherogenic; Fluoroquinolones; Gatifloxacin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Animal; Myocardial Ischemia; Rabbits; Randomized Controlled Trials as Topic; Roxithromycin; Treatment Outcome | 2003 |
1 trial(s) available for clarithromycin and Myocardial Ischemia
| Article | Year |
|---|---|
Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Chlamydia Infections; Chlamydophila pneumoniae; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Omeprazole; Risk Factors; Tinidazole | 1999 |
3 other study(ies) available for clarithromycin and Myocardial Ischemia
| Article | Year |
|---|---|
Clarithromycin plus linezolid as a sequential therapy for implantable-cardioverter-defibrillator infection caused by coagulase-negative staphylococci.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Defibrillators, Implantable; Echocardiography; Humans; Linezolid; Male; Myocardial Ischemia; Prosthesis-Related Infections; Staphylococcal Infections; Treatment Outcome | 2016 |
Clarithromycin use and risk of death in patients with ischemic heart disease.
Topics: Adult; Aged; Anti-Bacterial Agents; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Ischemia; Risk Factors | 2010 |
Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Heart Transplantation; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Myocardial Ischemia; Skin Diseases, Bacterial | 1995 |